Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 76, 67-80
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitorsBioorganic & Medicinal Chemistry, 2016
- Design, synthesis and biological evaluation of novel thiophene and theinopyrimidine derivatives as anticancer agentsMedicinal Chemistry Research, 2016
- Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell linesEuropean Journal of Medicinal Chemistry, 2016
- Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activitiesEuropean Journal of Medicinal Chemistry, 2014
- Design, synthesis and cytotoxic activity of some novel compounds containing pyrazolo[3,4-d]pyrimidines nucleusJournal of Chemical Sciences, 2013
- Synthesis, method optimization, anticancer activity of 2,3,7-trisubstituted Quinazoline derivatives and targeting EGFR-tyrosine kinase by rational approachArabian Journal of Chemistry, 2013
- Benzothiazoles: Search for anticancer agentsEuropean Journal of Medicinal Chemistry, 2012
- Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitorsJournal of Molecular Graphics and Modelling, 2010
- Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole–pyrrolo[2,1-c][1,4]benzodiazepine conjugatesBioorganic & Medicinal Chemistry, 2010
- Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agentsEuropean Journal of Medicinal Chemistry, 2005